Skip to main content
Premium Trial:

Request an Annual Quote

A Pharma Critic in Charge? Let the Lobbying Begin

Now that Tom Daschle has been recommended for the post of secretary of the US Department of Health and Human Services, advocacy groups are taking the opportunity to lobby him on his selection of a new FDA commissioner, according to this story in the Wall Street Journal. One new coalition formed expressly for this purpose has sent Daschle a letter saying that "relationships with the industry should be viewed as a 'positive qualification' for candidates, not as a black mark," the article says.

Over at Pharmalot, Ed Silverman blogs about the topic, noting that the push to name someone who has links to industry follows on speculation that frontrunners for the position include Steve Nissen and Joshua Sharfstein, both of whom have been highly critical of certain pharma companies.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.